AKO.B vs. CELH, COKE, FIZZ, PRMW, ZVIA, REED, KOF, MNST, FMX, and CCEP
Should you be buying Embotelladora Andina SA ADR Series B stock or one of its competitors? The main competitors of Embotelladora Andina SA ADR Series B include Celsius (CELH), Coca-Cola Consolidated (COKE), National Beverage (FIZZ), Primo Water (PRMW), Zevia PBC (ZVIA), Reed's (REED), Coca-Cola FEMSA (KOF), Monster Beverage (MNST), Fomento Económico Mexicano (FMX), and Coca-Cola Europacific Partners (CCEP). These companies are all part of the "bottled & canned soft drinks" industry.
Embotelladora Andina SA ADR Series B (NYSE:AKO.B) and Celsius (NASDAQ:CELH) are both consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.
Embotelladora Andina SA ADR Series B has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Celsius has a beta of 1.9, meaning that its share price is 90% more volatile than the S&P 500.
Celsius has lower revenue, but higher earnings than Embotelladora Andina SA ADR Series B. Embotelladora Andina SA ADR Series B is trading at a lower price-to-earnings ratio than Celsius, indicating that it is currently the more affordable of the two stocks.
In the previous week, Celsius had 44 more articles in the media than Embotelladora Andina SA ADR Series B. MarketBeat recorded 44 mentions for Celsius and 0 mentions for Embotelladora Andina SA ADR Series B. Celsius' average media sentiment score of 0.36 beat Embotelladora Andina SA ADR Series B's score of 0.00 indicating that Celsius is being referred to more favorably in the news media.
Celsius received 45 more outperform votes than Embotelladora Andina SA ADR Series B when rated by MarketBeat users. However, 65.31% of users gave Embotelladora Andina SA ADR Series B an outperform vote while only 63.84% of users gave Celsius an outperform vote.
1.6% of Embotelladora Andina SA ADR Series B shares are owned by institutional investors. Comparatively, 61.0% of Celsius shares are owned by institutional investors. 0.0% of Embotelladora Andina SA ADR Series B shares are owned by company insiders. Comparatively, 2.2% of Celsius shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Celsius has a net margin of 18.63% compared to Embotelladora Andina SA ADR Series B's net margin of 7.81%. Celsius' return on equity of 111.29% beat Embotelladora Andina SA ADR Series B's return on equity.
Celsius has a consensus target price of $76.51, indicating a potential upside of 59.33%. Given Celsius' higher probable upside, analysts plainly believe Celsius is more favorable than Embotelladora Andina SA ADR Series B.
Summary
Celsius beats Embotelladora Andina SA ADR Series B on 14 of the 17 factors compared between the two stocks.
Get Embotelladora Andina SA ADR Series B News Delivered to You Automatically
Sign up to receive the latest news and ratings for AKO.B and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AKO.B and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AKO.B vs. The Competition
Embotelladora Andina SA ADR Series B Competitors List
Related Companies and Tools
